Emerging treatment options for benign prostatic obstruction.
Curr Urol Rep
; 12(4): 247-54, 2011 Aug.
Article
en En
| MEDLINE
| ID: mdl-21475952
ABSTRACT
Benign prostatic obstruction (BPO) affects an increasing number of men with age. It can cause troublesome lower urinary tract symptoms, can have a negative impact on quality of life, and may be associated with significant morbidity. Currently available medication and surgical treatments are limited by adverse events, invasiveness, and patient compliance. This has driven research into the pathogenesis of benign prostatic hyperplasia and led to the development of novel pharmacological agents and minimally invasive therapeutic interventions. This review highlights emerging treatment options for BPO.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de Fosfodiesterasa
/
Hiperplasia Prostática
/
Procedimientos Quirúrgicos Urológicos Masculinos
/
Obstrucción Uretral
/
Trastornos Urinarios
/
Inmunosupresores
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Aspecto:
Patient_preference
Límite:
Humans
/
Male
Idioma:
En
Revista:
Curr Urol Rep
Asunto de la revista:
UROLOGIA
Año:
2011
Tipo del documento:
Article
País de afiliación:
Reino Unido